IL-18 level in patients undergoing coronary artery bypass grafting surgery or valve replacement: Which link with epicardial fat depot?

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 1011-1020

  Dozio, E ^a   Dogliotti, G ^a   Malavazos, A E ^b   Bandera, F ^b   Cassetti, G ^b   Vianello, E ^a   Zelaschi, R ^b   Barassi, A ^a   Pellissero, G ^b   Solimene, U ^a   Morricone, L ^b   Sigruener, A ^c   Tarabin, V ^c   Schmitz, G ^c   Menicanti, L ^b   Corsi Romanelli, M M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c Università di Regensburg   (Germany)

Author keywords

Adiposity; Cardiovascular diseases; Coronary artery bypass grafting surgery; Epicardial fat depot; Interleukin 18; Valve replacement

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 18 RECEPTOR1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN RECEPTOR; ORAL ANTIDIABETIC AGENT;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIAL ADIPOSE TISSUE; EPICARDIUM; FEMALE; GENE EXPRESSION; HEART VALVE REPLACEMENT; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; BLOOD VESSEL WALL; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DYSLIPIDEMIA; EPICARDIAL FAT; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; OPEN HEART SURGERY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT;

EID: 84872902799     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500418     Document Type: Article

References (31)

1. Smith DE. The biological paths of IL-1 family members IL-18 and IL-33. J Leukoc Biol 2011; 89:383-92.
2. Wang M, Markel TA, Meldrum DR. Interleukin 18 in the heart. Shock 2008; 30:3-10.
3. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, Yang XF. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 2009; 22:311-22.
4. Troseid M, Seljeflot I, Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol 2010; 23:9-11.
5. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104:1598-603.
6. Jefferis BJ, Papacosta O, Owen CG, et al. Interleukin 18 and coronary heart disease: Prospective study and systematic review. Atherosclerosis 2011; 217:227-33.
7. Sbarsi I, Falcone C, Boiocchi C, Campo I, Zorzetto M, De Silvestri A, Cuccia M. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol 2007; 20:145-54.
8. Dai-Bianco JP, Khandheria BK, Mookadam F, Gentile F, Sengupta PP. Management of asymptomatic severe aortic stenosis. J Am Coll Cardiol 2008; 52:1279-92.
9. Szkodzinski J, Blazelonis A, Wilczek K, et al. The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarctrelated artery. Int J Immunopathol Pharmacol 2009; 22:493-500.
10. Naito Y, Tsujino T, Wakabayashi K, et al. Increased interleukin-18 expression in nonrheumatic aortic valve stenosis. Int J Cardiol2010; 144:260-3.
11. Fix C, Bingham K, Carver W. Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine 2011; 53:19-28.
12. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108:2460-6.
13. Iacobellis G, Sharma AM. Obesity and the heart: redefinition of the relationship. Obes Rev 2007; 8:35-9.
14. Malavazos AE, Ermetici F, Coman C, Corsi MM, Morricone L, Ambrosi B. Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int J Cardiol 2007; 121:132-4.
15. Malavazos AE, Corsi MM, Ermetici F, Coman C, Sardanelli F, Rossi A, Morricone L, Ambrosi B. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007; 17:294-302.
16. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11:304-10.
17. Schejbal V. Epicardial fatty tissue of the right ventricle - morphology, morphometry and functional significance. Pneumologie 1989; 43:490-9.
18. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-5.
19. Blankenberg S, Luc G, Ducimetiere P, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003; 108:2453-9.
20. Skurk T, Kolb H, Muller-Scholze S, Rohrig K, Hauner H, Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005; 152:863-8.
21. Fain JN, Tichansky DS, Madan AK. Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes. Metabolism 2006; 55:1113-21.
22. Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol 2011; 43:1651-4.
23. Fiszer D, Rozwadowska N, Rychlewski L, Kosicki W, Kurpisz M. Identification of IL-18RAP mRNA truncated splice variants in human testis and the other human tissues. Cytokine 2007; 39:178-83.
24. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD 14+ human blood mononuclear cells. J Clin Invest 1998; 101:711-21.
25. Iacobellis G, di Gioia CR, Di Vito M, et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res 2009; 41:855-60.
26. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009; 22:1311-9.
27. Malavazos AE, Di Leo G, Secchi F, et al. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 2010; 105:1831-5.
28. Iacobellis G, Lonn E, Lamy A, Singh N, Sharma AM. Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol 2011; 146:452-4.
29. Liu Y, Jiang H, Liu W, Shang H, Tang Y, Zhu R, Li B. Effects of fluvastatin therapy on serum interleukin-18 and interleukin-10 levels in patients with acute coronary syndrome. Acta Cardiol 2010; 65:285-9.
30. Fujioka Y, Fukuda A, Ishida T, et al. Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN). J Atheroscler Thromb 2011; 18:8-15.
31. Lyngdoh T, Vollenweider P, Waeber G, Marques-Vidal P. Association of statins with inflammatory cytokines: a population-based Colaus study. Atherosclerosis 2011; 219:253-8.